EAM
QTTB icon

Erste Asset Management’s Q32 Bio QTTB Stock Holding History

Erste Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-60,000
Closed -$2.68M – 576
2024
Q3 		$2.68M Buy
60,000
+30,000
+100% +$1.1M 0.03% 290
2024
Q2 		$539K Hold
30,000
– – 0.01% 412
2024
Q1 		$511K Hold
30,000
– – 0.01% 419
2023
Q4 		$328K Hold
30,000
– – ﹤0.01% 457
2023
Q3 		$632K Sell
30,000
-3,194
-10% -$65.1K 0.01% 385
2023
Q2 		$528K Hold
33,194
– – 0.01% 413
2023
Q1 		$611K Hold
33,194
– – 0.01% 411
2022
Q4 		$748K Hold
33,194
– – 0.02% 389
2022
Q3 		$958K Hold
33,194
– – 0.02% 361
2022
Q2 		$1.18M Hold
33,194
– – 0.03% 335
2022
Q1 		$1.82M Buy
33,194
+11,111
+50% +$690K 0.03% 308
2021
Q4 		$1.47M Buy
22,083
+7,777
+54% +$755K 0.03% 323
2021
Q3 		$2.02M Hold
14,306
– – 0.04% 273
2021
Q2 		$1.86M Hold
14,306
– – 0.04% 290
2021
Q1 		$2.42M Hold
14,306
– – 0.06% 250
2020
Q4 		$3.01M Buy
14,306
+4,278
+43% +$827K 0.08% 223
2020
Q3 		$1.92M Buy
10,028
+2,361
+31% +$529K 0.07% 254
2020
Q2 		$2.09M Hold
7,667
– – 0.08% 227
2020
Q1 		$2.17M Hold
7,667
– – 0.13% 180
2019
Q4 		$2.9M Hold
7,667
– – 0.13% 157
2019
Q3 		$2.5M Hold
7,667
– – 0.13% 160
2019
Q2 		$2.69M Buy
7,667
+5,556
+263% +$2.18M 0.14% 148
2019
Q1 		$1.06M Buy
+2,111
New +$944K 0.06% 243

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Erste Asset Management's QTTB Position: Q4 2024 in Review

Erste Asset Management sold out of Q32 Bio (QTTB) in Q4 2024, closing a stake of 60,000 shares — an estimated $2.68M sold.

Erste Asset Management first reported a position in QTTB in Q1 2019 and held it in 23 quarters. The position peaked at $3.01M in Q4 2020. 92 funds tracked by Wall St. Rank hold QTTB as of Q4 2024.

  • Erste Asset Management reported no remaining Q32 Bio position as of Q4 2024 after selling out during the quarter.
  • Erste Asset Management sold 60,000 Q32 Bio shares in Q4 2024, an estimated $2.68M.
  • Erste Asset Management first reported a position in Q32 Bio in Q1 2019 and held it in 23 quarters.
  • Erste Asset Management's Q32 Bio position peaked at $3.01M in Q4 2020.
  • 92 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2024.

Based on Erste Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.